A
Acer Therapeutics Inc
F:P6NA
Acer Therapeutics Inc
F:P6NA
Price:
0.804
EUR
Market Closed
Market Cap:
€28.8m
Relative Value
There is not enough data to reliably calculate the relative value of P6NA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
P6NA
Relative Value
Base Case
Not Available
Multiples Across Competitors
P6NA Competitors Multiples
Acer Therapeutics Inc Competitors
Acer Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Acer Therapeutics Inc
F:P6NA
|
28.8m EUR | 0 | -1.3 | -1.4 | -1.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
934.4B USD | 14.4 | 45.5 | 30.7 | 32.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.8B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.7B CHF | 4.3 | 20.4 | 12 | 13.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
238.2B CHF | 5.5 | 22.1 | 13.7 | 17.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.2B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
284.1B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.2B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.5 | 17.2 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
